Pharmacokinetic interactions between depot medroxyprogesterone acetate and combination antiretroviral therapy
To access this article, please choose from the options below
Support for this work was provided by funds from the United States Agency for International Development (USAID) (cooperative agreements nos. AID/CCP-3079-A-00-5022-00 and GPO-A-OO-05-00022-00), the Contraceptive and Reproductive Health Technologies Research and Utilization Program, and the University of North Carolina at Chapel Hill Center for AIDS Research (a National Institutes of Health-funded program; P30 AI50410). The views expressed in this document, however, do not necessarily reflect those of USAID.
PII: S0015-0282(07)02999-8
doi:10.1016/j.fertnstert.2007.07.1348
© 2008 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

